AbbVie: The Path To 30% Annual Returns
skodonnell/iStock via Getty Images
Pharmaceutical giant AbbVie (ABBV) has long enjoyed the financial windfall of ownership rights to the world’s top-selling drug, Humira. While Humira has filled AbbVie’s coffers with many billions of dollars over the years,…
